ClinConnect ClinConnect Logo
Search / Trial NCT06833697

A Comparative Study of Erector Spinae Plane Block and Serratus Posterior Superior Intercostal Plane Block on Postoperative Opioid Consumption Following Breast and Axillary Dissection Surgery

Launched by MEDIPOL UNIVERSITY · Feb 18, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Breast Surgery Postoperative Pain Erector Spinae Plane Block Serratus Posterior Superior Intercostal Plane Block Opioid Consumption Ultrasound Guided Nerve Block

ClinConnect Summary

This clinical trial is looking at two different methods to help manage pain after breast surgery: the erector spinae plane block (ESPB) and the serratus posterior superior intercostal plane block (SPSIP). Both techniques involve using ultrasound to guide the placement of medication near the nerves, which can help reduce pain. The study aims to see which method leads to a lower use of opioids for pain relief after surgery, as opioids can cause unwanted side effects like nausea and breathing difficulties.

To participate in the trial, you need to be between 18 and 80 years old, scheduled for breast surgery with lymph node removal, and generally in good health (classed as ASA physical status I-III). The trial is currently recruiting participants, so if you’re eligible, you can expect to be involved in a study that might help improve pain management after surgery for future patients. Your pain levels and any side effects you experience will be carefully monitored throughout the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • aged 18-80 years
  • Classified as ASA (American Society of Anesthesiologists) physical status I-III
  • Scheduled for breast surgery with axillary lymph node dissection
  • Exclusion Criteria:
  • Patients with a history of allergies
  • allergic to local anesthetics
  • pregnant women
  • psychiatric or neurological disorders

About Medipol University

Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported